The drugmaker Moderna out of Cambridge, Massachusetts announced that their coronavirus vaccine appears to be safe and able to stimulate an immune response against the COVID-19 virus. The initial results are from testing performed on eight volunteers. The second phase involving 600 people will begin soon and is on an accelerated timeline.